Form 4 for VNDA Vanda Pharmaceuticals Inc.
Accepted 2026-05-20 16:49:38 ET · period of report 2026-05-18 · accession 0001802653-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 16:49 | 2026-05-18 | VNDA | Mitchell Stephen Ray | Dir | G - Gift | $0.00 | -25.8K | 71.2K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-18 | G | D | 25,836 | $0.00 | 71,246 | D | — | — | (F1) Represents a gift to a charitable organization. |